Position in CCCC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$41,410,467
+$17,550,056 QoQ
Shares Held
8,867,338
-2.3% QoQ
Ownership
7.21%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,792 across 523 Biotechnology names. CCCC ranks #65 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CCCC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,410,467 | 8,867,338 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $41,385,549 | 8,862,002 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $23,860,411 | 9,072,400 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,154,973 | 8,981,662 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $11,037,908 | 4,972,032 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $6,798,486 | 4,754,188 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $6,472,524 | 4,045,329 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,822,087 | 3,839,469 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $13,258,961 | 2,326,134 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $5,257,271 | 1,137,938 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $4,200,872 | 514,183 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,160,174 | 205,341 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $582,319 | 313,077 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $662,855 | 241,039 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $923,589 | 294,138 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,237,270 | 379,199 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,020,269 | 344,387 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,434,135 | 455,456 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $15,952,693 | 657,572 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $29,574,731 | 918,470 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,961,486 | 290,096 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,450,951 | 276,188 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $784,002 | 21,195 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $301,747 | 9,108 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||